| Amino Acid Profile, Qn, Plasma |
| Test |
In Range |
Out Of Range |
Units |
Reference |
| Taurine |
96.3 |
|
umol/L |
29.2 - 132.3 |
| Aspartate |
3.1 |
|
umol/L |
0.9 - 7.4 |
| Hydroxyproline |
17.9 |
|
umol/L |
4.7 - 35.2 |
| Threonine |
92.3 |
|
umol/L |
67.8 - 211.6 |
| Serine |
57.0 |
|
umol/L |
48.7 - 145.2 |
| |
| Asparagine |
|
86.4 H |
umol/L |
29.5 - 84.5 |
| Glutamate |
65.1 |
|
umol/L |
18.1 - 155.9 |
| Glutamine |
591.3 |
|
umol/L |
332.0 - 754.0 |
| Sarcosine |
2.3 |
|
umol/L |
0.0 - 4.0 |
| Alpha-aminoadipate |
0.8 |
|
umol/L |
0.0 - 2.2 |
| |
| Proline |
158.5 |
|
umol/L |
84.8 - 352.5 |
| Glycine |
237.7 |
|
umol/L |
132.0 - 467.0 |
| Alanine |
306.9 |
|
umol/L |
124.8 - 564.2 |
| Citrulline |
30.8 |
|
umol/L |
13.7 - 63.2 |
| Alpha-aminobutyrate |
12.2 |
|
umol/L |
5.4 - 34.5 |
| |
| Valine |
161.5 |
|
umol/L |
102.6 - 345.4 |
| Cystine |
40.0 |
|
umol/L |
13.5 - 60.2 |
| Methionine |
19.4 |
|
umol/L |
12.7 - 41.1 |
| Homocitrulline |
< 0.5 |
|
umol/L |
0.0 - 1.7 |
| Cystathionine |
0.1 |
|
umol/L |
0.0 - 0.7 |
| |
| Alloisoleucine |
1.4 |
|
umol/L |
0.4 - 3.2 |
| Isoleucine |
46.6 |
|
umol/L |
27.7 - 112.8 |
| Leucine |
91.2 |
|
umol/L |
54.9 - 205.0 |
| Tyrosine |
37.2 |
|
umol/L |
31.1 - 118.1 |
| Phenylalenine |
42.6 |
|
umol/L |
33.6 - 101.9 |
| |
| Argininosuccinate |
0.1 |
|
umol/L |
0.0 - 3.0 |
| Beta-alanine |
1.7 |
|
umol/L |
1.7 - 9.0 |
| Beta-aminoisobutyrate |
0.6 |
|
umol/L |
0.3 - 4.3 |
| Homocystine |
< 0.1 |
|
umol/L |
0.0 - 0.1 |
| Gamma-aminobutyrate |
< 0.4 |
|
umol/L |
0.0 - 0.3 |
| |
| Tryptophan |
43.9 |
|
umol/L |
23.5 - 93.0 |
| Hydroxylysine |
0.3 |
|
umol/L |
0.1 - 0.8 |
| Ornithine |
59.0 |
|
umol/L |
30.5 - 131.4 |
| Lysine |
135.8 |
|
umol/L |
94.0 - 278.0 |
| Histidine |
62.1 |
|
umol/L |
47.2 - 98.5 |
| Arginine |
82.1 |
|
umol/L |
32.0 - 150.0 |
| |
| Interpretation |
| No evidence of aminoacidopathy by quantitaive plasma amino acid analysis. |
| |
| Lipid Panel |
| Cholesterol, Total |
|
212 H |
mg/dL |
100 - 199 |
| Triglycerides |
66 |
|
mg/dL |
0 - 149 |
| HDL Cholesterol |
105 |
|
mg/dL |
> 39 |
| Comment: According to ATP-III Guidelines, HDL-C > 59 is considered a negative risk factor for CHD. |
| VLDL Cholesterol Cal |
13 |
|
mg/dL |
5 - 40 |
| LDL Cholesterol Calc |
94 |
|
mg/dL |
0 - 99 |
| | |
| Total Glutathione |
246 |
|
ug/mL |
225 - 386 |
| |
| Vitamin D, 25-Hydroxy |
41.7 |
|
ng/mL |
30.0 - 100.0 |
| Vitamin D deficiency has been defined by the Institute of Medicnine and an Endocrine Society practice guideline as a level of serum 25-OH vitamin D less than 20 ng/mL (1,2). The Endocrine Society went on to further define vitamin D insufficiency as a level between 21 and 29 ng/mL (2)> |
| 1. IOM (Institute of Medicine). 2010. Dietary reference intakes for calcium and D. Washington DC: The National Academies Press. |
| 2. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. JCEM. 2011 Jul; 96(7):1911-30. |
| |
| Homocyst(e)ine, Plasma |
11.3 |
|
umol/L |
0.0 - 15.0 |
| Triiodothyronine (T3) |
100 |
|
ng/dL |
71 - 180 |
| Complement, Total (CH50) |
|
>: 63 H |
U/mL |
22 - 60 |